ENGN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Based on the data provided, enGene Holdings Inc (ENGN) does not present a compelling buy opportunity for a beginner investor with a long-term focus at this time. The lack of strong positive catalysts, weak financial performance, and absence of significant trading signals suggest a cautious approach. Holding off on investment until clearer growth trends or catalysts emerge would be prudent.
The technical indicators are mixed. While the moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the MACD is below 0 and negatively contracting, and the RSI is neutral at 51.786. The stock is trading near its pivot level of 10.066, with resistance at 10.522 and support at 9.61. Overall, there is no strong technical signal for immediate action.
Jefferies initiated coverage with a Buy rating and a $28 price target, citing competitive interim data and a strong differentiation in the company's pipeline. The company's detalimogene is positioned to stand out in its market.
The company recently filed a shelf registration for up to $40 million, which could lead to potential dilution of shares. Additionally, the financials show no revenue growth and a significant net loss of -$37.88M in Q4 2025, despite some YoY improvement in net income and EPS. There are no significant hedge fund or insider trading trends, and no recent congress trading data.
In Q4 2025, the company reported no revenue growth (0% YoY), a net loss of -$37.88M (up 147.60% YoY), and an EPS of -0.74 (up 117.65% YoY). While the YoY improvement in net income and EPS is notable, the company remains unprofitable with no revenue.
Jefferies recently initiated coverage with a Buy rating and a $28 price target, highlighting the company's competitive interim data and differentiation in its pipeline. However, the key update for its pivotal study is not expected until the second half of 2026, making this a longer-term catalyst.
